ATNM vs XLV
Actinium Pharmaceuticals Inc (ATNM) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
XLV does not have a complete income-statement cache yet.
ATNM currently screens at market cap $33.9M. XLV currently screens at market cap $0.
Not investment advice. Open the ATNM and XLV stock pages for the full models.
Not investment advice.